aod 9604 peptide vs semaglutide AOD-9604 MOTS-c vs Tesamorelin vs vs Tirzepatide: Which Is Best for Weight Loss and Metabolic Health? AOD 9604: The Ultimate Guide
Description
Semaglutide carries a boxed warning about thyroid C-cell tumors in animals and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Semaglutide is a single GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Final Thoughts Its my belief that doctors are severely undereducated when it comes to managing the autoimmune thyroid condition known as Hashimotos
Potential Benefits Being Studied Significant Weight Reduction Clinical studies have shown that Retatrutide may produce substantial body weight reductions compared with placebo groups
Weeks 17+: 12.5mg or 15mg once weekly (maximum)
Funding This study, the Rapid Service Fee, and the Open Access fee were funded by Eli Lilly and Company
